Enhanced Mechanical Properties and Anti-Inflammation of Poly(L-Lactic Acid) by Stereocomplexes of PLLA/PDLA and Surface-Modified Magnesium Hydroxide Nanoparticles

Polymers (Basel). 2022 Sep 10;14(18):3790. doi: 10.3390/polym14183790.

Abstract

Poly(L-lactic acid) (PLLA), as a biodegradable polymer, has attracted attention for use as a biomaterial. In order to apply PLLA as a cardiovascular stent, stronger mechanical properties and anti-inflammatory effects against acidic by-products are required. In this study, PLLA/PDLA stereocomplex microparticles (SC) were developed and surface-modified magnesium hydroxide (MH) nanoparticles with oligolactide were combined with these PLLA composites. The SC improved the mechanical properties of the PLLA composites through the formation of stereocomplex structures. The surface-modified MH nanoparticles showed enhanced mechanical properties due to the stereocomplex structures formed by PLLA chains and inhibited inflammatory responses by pH neutralization as a result of MH. Additionally, the MH nanoparticles containing PLLA composites had antibacterial effects and increased the viability of human vascular endothelial cells. This technology is expected to have great potential in the development of PLLA composite materials for the production of various medical devices, such as cardiovascular stents.

Keywords: Poly(D–lactic acid); Poly(L–lactic acid); biodegradable vascular scaffold; magnesium hydroxide; nanoparticles; stereocomplex.

Grants and funding

This work was supported by the Basic Science Research Program (2020R1A2B5B03002344) and the Bio & Medical Technology Development Program (2018M3A9E2024579) through the National Research Foundation of Korea, funded by the Ministry of Science and ICT (MSIT); a Korea Medical Device Development Fund grant, funded by the Korean government (the Ministry of Science and ICT; the Ministry of Trade, Industry and Energy; the Ministry of Health & Welfare, Republic of Korea); and the Ministry of Food and Drug Safety (202011A05–05); and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI18C0089).